NCT00731445View on ClinicalTrials.gov

Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

June 30, 2012

Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG

Z-208

Oral pills taken daily; 8mg, 12mg, 16mg, 4mg

Trial Locations (1)

Unknown

The University of Tokyo Hospital, Tokyo

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY

NCT00731445 - Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) | Biotech Hunter | Biotech Hunter